|
 |
 |
- Applied NeuroSolutions Press Releases
- APPLIED NEUROSOLUTIONS ANNOUNCES 2005 RESULTS - Company Provides Corporate Update - March 23, 2006
- Applied NeuroSolutions’ Founding Scientist Quoted In Investor’s Business Daily (IBD) - January 09, 2006
- Increase in Specific, Abnormal Brain Protein May Predict Onset of Alzheimer’s Disease, Study Shows - January 04, 2006
- Applied NeuroSolutions Renews Agreement with Peter Davies, Ph.D. - December 12, 2005
- Applied NeuroSolutions Retains Financial Dynamics as its Financial Communications and Investor Relations Agency - December 06, 2005
- Applied NeuroSolutions Appoints Inamed Executive Robert S. Vaters to its Board of Directors - October 20, 2005
- Applied NeuroSolutions’ Alzheimer’s Test Expected to be Featured on “Lou Adler’s Medical Journal” Radio Report - October 18, 2005
- Applied NeuroSolutions Takes First Step In Commercialization of Diagnostic Alzheimer’s Disease Test - September 08, 2005
- Applied NeuroSolutions, Inc. President and CEO Interviewed on “Business Talk This Morning” Radio Show - August 31, 2005
- Applied NeuroSolutions Profiled in Chicago Sun-Times - August 08, 2005
- Applied NeuroSolutions' Diagnostic Alzheimer's Disease Test Focus of Story on CBS News TV Stations - August 03, 2005
- Applied NeuroSolutions Adds Jay B. Langner, Board Chairman of Montefiore Medical Center, to its Board of Directors - July 26, 2005
- Applied NeuroSolutions Sees Abnormal Cell Division as Possible Precursor of Alzheimer's Disease- June 20, 2005
- Applied NeuroSolutions Announces Research Program For Novel Approach To Alzheimer's Disease Therapeutics- June 06, 2005
- Applied NeuroSolutions Biomarker May Predict Alzheimer's Disease Progression - May 25, 2005
- Applied NeuroSolutions Ready to Ship First Research Mouse to Exhibit Key Alzheimer's Pathology - April 06, 2005
- Applied NeuroSolutions Receives U.S. Patent on Alzheimer's Blood Test Technology - March 10, 2005
- Johns Hopkins "Memory Bulletin" Comments on Applied NeuroSolutions Alzheimer's Disease Diagnostic - February 28, 2005
- bioMérieux to License Applied NeuroSolutions Technology to Diagnose Alzheimers Disease - December 13, 2004
- Applied NeuroSolutions p-tau 231 Assay Greatly Improves Early Stage Alzheimers Disease Detection Journal of Internal Medicine Study Shows - September 30, 2004
- Applied NeuroSolutions Announces Resignation of Chief Executive Officer and Elevation of John F. DeBernardis, Ph.D. to Chief Executive Officer - September 28, 2004
- Dr. Peter Davies Reviews And Questions Conventional Approaches In Alzheimers Disease Research - July 21, 2004
- Applied Neurosolutions' (Otc Bb: Apns) Biomarker Improves On Early Diagnosis Of Alzheimers Disease - July 20, 2004
- Applied Neurosolutions Bio-Marker Determined To Be Useful In Diagnosing Mildly Cognitively Impaired (Mci) Patients Assay May Detect Early-Stage Alzheimers Disease In Patients - July 19, 2004
- Applied Neurosolutions Founding Scientist Co-Chairs Alzheimers Panel To Examine New Research Models - July 19, 2004
- Applied NeuroSolutions Appoints New Board Member - June 18, 2004
- APNS Announces Delisting of Unauthorized Listing on Berlin-Bremen Stock Exchange - June 2, 2004
- Applied NeuroSolutions Completes $8 Million Private Placement Converts Bridge Loans to Equity - Feb. 12, 2004
- Independent Study Concludes Applied NeuroSolutions Alzheimers Test Exceeds Industry Goals and Standards - Jan. 26, 2004
- Applied NeuroSolutions Founding Scientist Receives Ten Year NIH Award - Dec. 15, 2003
- APNS Discusses Diagnosing Alzheimer's Disease on CEOcast Today - Dec. 10, 2003
- Hemoxymed IS NOW Applied NeuroSolutions, Inc. - Nov. 25, 2003
- Applied NeuroSolutions Signs Agreement with Novartis - Nov. 19, 2003
- Hemoxymed, Inc. To Be Re-Named Applied NeuroSolutions, Inc. - Oct. 14, 2003
- Hemoxymed to Market Unique Animal Model for Alzheimer's Disease - Sept. 16, 2003
|
|
|